Global Blood Transfusion Diagnostics Market By Product By Application, By End Use & Region: Segmental Insights, Growth, Comparative Analysis, Trends and Forecast, 2023 – 2031

  • Industry: Healthcare
  • Report ID: TNR-110-910
  • Number of Pages: 420
  • Table/Charts : Yes
  • November, 2023
  • Base Year : 2024
  • No. of Companies : 10+
  • No. of Countries : 29
  • Views : 12134
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

Global Blood Transfusion Diagnostics Market was valued at US$ 4.70 Billion in 2022, Growing at an Estimated CAGR of 5.87% from 2023-2031.

Blood transfusion diagnostics involves a set of tests conducted to ensure compatibility between the donor’s blood and the recipient’s blood during a transfusion. It focuses on identifying blood groups (A, B, AB, O) and Rh factor (positive or negative), preventing adverse reactions. The process includes ABO and Rh typing, where specific antigens and antibodies are matched to prevent immune reactions. Additionally, cross-matching tests verify compatibility by mixing donor and recipient blood samples in controlled conditions. These diagnostics also screen for infectious diseases like HIV, hepatitis, and syphilis in the donor’s blood to safeguard the recipient’s health. Blood transfusion diagnostics play a crucial role in maintaining the safety and effectiveness of blood transfusions, saving lives while minimizing risks.

Among products, reagents & kits are dominating in terms of demand. Surveys conducted within the medical and healthcare industry indicate a consistent requirement for high-quality and specialized reagents and kits for blood typing, cross-matching, and infectious disease screening. These consumables are crucial for ensuring the safety and compatibility of blood transfusions.

Global Blood Transfusion Diagnostics Market Revenue & Forecast, (US$ Million), 2015 – 2031

COVID-19 Impact Analysis on Global Blood Transfusion Diagnostics Market

The blood transfusion diagnostics market experienced distinct shifts before and after COVID-19. Pre-pandemic, the market was steadily growing due to the consistent demand for blood typing, compatibility testing, and disease screening in healthcare settings. However, the onset of the pandemic brought both challenges and opportunities. During COVID-19, healthcare systems worldwide faced unprecedented strain, and while routine medical procedures were affected, the need for safe and accurate blood transfusions remained crucial. Blood Transfusion Diagnostics played a vital role in maintaining the safety of blood supplies and preventing transmission of infections. The pandemic emphasized the significance of robust diagnostic systems to ensure patient well-being. As the world emerges from the crisis, the blood transfusion diagnostics market is poised to adapt to new healthcare norms, combining technology and safety measures to continue delivering reliable blood compatibility testing and disease screening.

Report Coverage and Deliverables: 

An important driver for the blood transfusion diagnostics market is the rising demand for blood transfusions globally. According to surveys conducted by healthcare organizations, the prevalence of medical conditions requiring blood transfusions, such as surgeries, trauma cases, and chronic diseases, is increasing. This drives the need for accurate blood grouping, compatibility testing, and disease screening to ensure safe and effective transfusions. For instance, a notable increase in surgical procedures in various countries has contributed to the consistent demand for reliable blood transfusion diagnostics, highlighting the critical role of these diagnostics in healthcare. A significant restraint on the blood transfusion diagnostics market is the stringent regulatory landscape governing diagnostic products. Database records from regulatory authorities showcase the extensive regulatory scrutiny that blood transfusion diagnostic products undergo before approval. The thorough evaluation process, although essential for patient safety, can lead to extended product development timelines and increased costs. Surveys among diagnostic manufacturers indicate that navigating these complex regulatory requirements can pose challenges, especially for smaller companies with limited resources. This can potentially impede rapid market entry and innovation, hindering the market’s growth to some extent.

Blood grouping remains a dominant application due to its critical role in ensuring blood compatibility during transfusions. Surveys conducted among healthcare professionals underscore the ongoing need for accurate blood typing and cross-matching, especially in emergency situations and surgeries. The demand for reliable blood grouping solutions has consistently remained high.

North America dominated the global blood transfusion diagnostics market in 2022. The region holds a substantial market share due to its robust healthcare infrastructure and advanced diagnostic adoption. According to surveys by healthcare institutions, North America exhibits consistent demand for precise blood transfusion diagnostics due to the region’s high volume of medical procedures and surgeries. Regulatory databases highlight the stringent quality norms upheld in the region, indicating its commitment to maintaining diagnostic accuracy and patient safety. The American Red Cross reports that the US alone requires over 13,000 blood donations daily, emphasizing the substantial demand for accurate blood grouping and compatibility testing.

Competitive Landscape

The report provides both, qualitative and quantitative research of global blood transfusion diagnostics market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the global blood transfusion diagnostics market are

  • Abbott
  • Beckman Coulter, Inc.
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Grifols, S.A.
  • MedGenome
  • Ortho Clinical Diagnostics
  • Quotient Suisse SA
  • Siemens Healthcare Private Limited
  • Other Industry Participants

Global Blood Transfusion Diagnostics Market Report Coverage

Report Specifications Details
Market Revenue in 2022 US$ 4.70 Billion
Market Size Forecast by 2031 US$ 6.68 Billion
Growth Rate (CAGR) 5.87%
Historic Data 2015 – 2021
Base Year for Estimation 2022
Forecast Period 2023 – 2031
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Product, By Application, By End Use
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players Abbott, Beckman Coulter, Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Grifols, S.A., MedGenome, Ortho Clinical Diagnostics, Quotient Suisse SA, Siemens Healthcare Private Limited, Other Industry Participants
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free): – +81 663-386-8111

South Korea (Toll-Free): – +82-808- 703-126

Saudi Arabia (Toll-Free): – +966 800 850 1643

United States: +1 302-232-5106

United Kingdom: +447537105080

E-mail:  askanexpert@thenicheresearch.com

 

 

Global Blood Transfusion Diagnostics Market:

By Product

  • Reagents and kits
  • Instruments
  • Others

By Application

  • Blood Grouping
  • Disease Screening
    • Serological disease screening
    • Molecular disease screening

By End-use

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Table of Contents

.

1.Market Scope
1.1.Market Segmentation
1.2.Years Considered
1.2.1.Historic Years: 2015 – 2021
1.2.2.Base Year: 2022
1.2.3.Forecast Years: 2023 – 2031
2.Key Target Audiences
3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire
3.1.2.Global Percentage Breakdown
3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)
3.2.Secondary Research
3.2.1.Paid Databases
3.2.2.Secondary Sources
3.3.Market Size Estimates
3.3.1.Top-Down Approach
3.3.2.Bottom-Up Approach
3.4.Data Triangulation Methodology
3.5.Research Assumptions
4.Recommendations and Insights from TNR’sPerspective**
5.Holistic Overview of Blood Transfusion Diagnostics Market
6.Market Synopsis: Blood Transfusion Diagnostics Market
7.Blood Transfusion Diagnostics Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition
7.1.2.Industry Development
7.2.Market Dynamics
7.2.1.Drivers
7.2.2.Restraints
7.2.3.Opportunities
7.2.4.Challenges
7.3.Trends in Blood Transfusion Diagnostics Market
7.4.Market Determinants Radar Chart
7.5.Macro-Economic and Micro-Economic Indicators: Blood Transfusion Diagnostics Market
7.6.Porter’s Five Force Analysis
7.7.Impact of Covid-19 on Blood Transfusion Diagnostics Market
7.8.PESTEL Analysis
8.Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2023 – 2031
8.1.Overview
8.1.1.Global Blood Transfusion Diagnostics Market Revenue (US$ Mn)
8.2.Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
8.2.1.Reagents and Kits
8.2.1.1.Definition
8.2.1.2.Market Estimation and Penetration, 2015 – 2022
8.2.1.3.Market Forecast, 2023 – 2031
8.2.1.4.Compound Annual Growth Rate (CAGR)
8.2.1.5.Regional Bifurcation
8.2.1.5.1.North America
8.2.1.5.1.1.Market Estimation, 2015 – 2022
8.2.1.5.1.2.Market Forecast, 2023 – 2031
8.2.1.5.2.Europe
8.2.1.5.2.1.Market Estimation, 2015 – 2022
8.2.1.5.2.2.Market Forecast, 2023 – 2031
8.2.1.5.3.Asia Pacific
8.2.1.5.3.1.Market Estimation, 2015 – 2022
8.2.1.5.3.2.Market Forecast, 2023 – 2031
8.2.1.5.4.Middle East and Africa
8.2.1.5.4.1.Market Estimation, 2015 – 2022
8.2.1.5.4.2.Market Forecast, 2023 – 2031
8.2.1.5.5.Latin America
8.2.1.5.5.1.Market Estimation, 2015 – 2022
8.2.1.5.5.2.Market Forecast, 2023 – 2031
8.2.2.Instruments
8.2.2.1.Definition
8.2.2.2.Market Estimation and Penetration, 2015 – 2022
8.2.2.3.Market Forecast, 2023 – 2031
8.2.2.4.Compound Annual Growth Rate (CAGR)
8.2.2.5.Regional Bifurcation
8.2.2.5.1.North America
8.2.2.5.1.1.Market Estimation, 2015 – 2022
8.2.2.5.1.2.Market Forecast, 2023 – 2031
8.2.2.5.2.Europe
8.2.2.5.2.1.Market Estimation, 2015 – 2022
8.2.2.5.2.2.Market Forecast, 2023 – 2031
8.2.2.5.3.Asia Pacific
8.2.2.5.3.1.Market Estimation, 2015 – 2022
8.2.2.5.3.2.Market Forecast, 2023 – 2031
8.2.2.5.4.Middle East and Africa
8.2.2.5.4.1.Market Estimation, 2015 – 2022
8.2.2.5.4.2.Market Forecast, 2023 – 2031
8.2.2.5.5.Latin America
8.2.2.5.5.1.Market Estimation, 2015 – 2022
8.2.2.5.5.2.Market Forecast, 2023 – 2031
8.2.3.Others
8.2.3.1.Definition
8.2.3.2.Market Estimation and Penetration, 2015 – 2022
8.2.3.3.Market Forecast, 2023 – 2031
8.2.3.4.Compound Annual Growth Rate (CAGR)
8.2.3.5.Regional Bifurcation
8.2.3.5.1.North America
8.2.3.5.1.1.Market Estimation, 2015 – 2022
8.2.3.5.1.2.Market Forecast, 2023 – 2031
8.2.3.5.2.Europe
8.2.3.5.2.1.Market Estimation, 2015 – 2022
8.2.3.5.2.2.Market Forecast, 2023 – 2031
8.2.3.5.3.Asia Pacific
8.2.3.5.3.1.Market Estimation, 2015 – 2022
8.2.3.5.3.2.Market Forecast, 2023 – 2031
8.2.3.5.4.Middle East and Africa
8.2.3.5.4.1.Market Estimation, 2015 – 2022
8.2.3.5.4.2.Market Forecast, 2023 – 2031
8.2.3.5.5.Latin America
8.2.3.5.5.1.Market Estimation, 2015 – 2022
8.2.3.5.5.2.Market Forecast, 2023 – 2031
8.3.Key Segment for Channeling Investments
8.3.1.By Product
9.Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2023 – 2031
9.1.Overview
9.2.Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1.Blood Grouping
9.2.1.1.Definition
9.2.1.2.Market Estimation and Penetration, 2015 – 2022
9.2.1.3.Market Forecast, 2023 – 2031
9.2.1.4.Compound Annual Growth Rate (CAGR)
9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2015 – 2022
9.2.1.5.1.2.Market Forecast, 2023 – 2031
9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2015 – 2022
9.2.1.5.2.2.Market Forecast, 2023 – 2031
9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2015 – 2022
9.2.1.5.3.2.Market Forecast, 2023 – 2031
9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2015 – 2022
9.2.1.5.4.2.Market Forecast, 2023 – 2031
9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2015 – 2022
9.2.1.5.5.2.Market Forecast, 2023 – 2031
9.2.2.Disease Screening (Definition, Market Estimation and Penetration, 2015 – 2022, Market Estimation (2015 – 2022), Market Forecast (2023 – 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Serological disease screening, Molecular disease screening)
9.2.2.1.Serological disease screening
9.2.2.2.Molecular disease screening
9.3.Key Segment for Channeling Investments
9.3.1.By Application
10.Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2023 – 2031
10.1.Overview
10.2.Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
10.2.1.Hospitals
10.2.1.1.Definition
10.2.1.2.Market Estimation and Penetration, 2015 – 2022
10.2.1.3.Market Forecast, 2023 – 2031
10.2.1.4.Compound Annual Growth Rate (CAGR)
10.2.1.5.Regional Bifurcation
10.2.1.5.1.North America
10.2.1.5.1.1.Market Estimation, 2015 – 2022
10.2.1.5.1.2.Market Forecast, 2023 – 2031
10.2.1.5.2.Europe
10.2.1.5.2.1.Market Estimation, 2015 – 2022
10.2.1.5.2.2.Market Forecast, 2023 – 2031
10.2.1.5.3.Asia Pacific
10.2.1.5.3.1.Market Estimation, 2015 – 2022
10.2.1.5.3.2.Market Forecast, 2023 – 2031
10.2.1.5.4.Middle East and Africa
10.2.1.5.4.1.Market Estimation, 2015 – 2022
10.2.1.5.4.2.Market Forecast, 2023 – 2031
10.2.1.5.5.Latin America
10.2.1.5.5.1.Market Estimation, 2015 – 2022
10.2.1.5.5.2.Market Forecast, 2023 – 2031
10.2.2.Blood Banks
10.2.2.1.Definition
10.2.2.2.Market Estimation and Penetration, 2015 – 2022
10.2.2.3.Market Forecast, 2023 – 2031
10.2.2.4.Compound Annual Growth Rate (CAGR)
10.2.2.5.Regional Bifurcation
10.2.2.5.1.North America
10.2.2.5.1.1.Market Estimation, 2015 – 2022
10.2.2.5.1.2.Market Forecast, 2023 – 2031
10.2.2.5.2.Europe
10.2.2.5.2.1.Market Estimation, 2015 – 2022
10.2.2.5.2.2.Market Forecast, 2023 – 2031
10.2.2.5.3.Asia Pacific
10.2.2.5.3.1.Market Estimation, 2015 – 2022
10.2.2.5.3.2.Market Forecast, 2023 – 2031
10.2.2.5.4.Middle East and Africa
10.2.2.5.4.1.Market Estimation, 2015 – 2022
10.2.2.5.4.2.Market Forecast, 2023 – 2031
10.2.2.5.5.Latin America
10.2.2.5.5.1.Market Estimation, 2015 – 2022
10.2.2.5.5.2.Market Forecast, 2023 – 2031
10.2.3.Diagnostic Laboratories
10.2.3.1.Definition
10.2.3.2.Market Estimation and Penetration, 2015 – 2022
10.2.3.3.Market Forecast, 2023 – 2031
10.2.3.4.Compound Annual Growth Rate (CAGR)
10.2.3.5.Regional Bifurcation
10.2.3.5.1.North America
10.2.3.5.1.1.Market Estimation, 2015 – 2022
10.2.3.5.1.2.Market Forecast, 2023 – 2031
10.2.3.5.2.Europe
10.2.3.5.2.1.Market Estimation, 2015 – 2022
10.2.3.5.2.2.Market Forecast, 2023 – 2031
10.2.3.5.3.Asia Pacific
10.2.3.5.3.1.Market Estimation, 2015 – 2022
10.2.3.5.3.2.Market Forecast, 2023 – 2031
10.2.3.5.4.Middle East and Africa
10.2.3.5.4.1.Market Estimation, 2015 – 2022
10.2.3.5.4.2.Market Forecast, 2023 – 2031
10.2.3.5.5.Latin America
10.2.3.5.5.1.Market Estimation, 2015 – 2022
10.2.3.5.5.2.Market Forecast, 2023 – 2031
10.2.4.Others
10.2.4.1.Definition
10.2.4.2.Market Estimation and Penetration, 2015 – 2022
10.2.4.3.Market Forecast, 2023 – 2031
10.2.4.4.Compound Annual Growth Rate (CAGR)
10.2.4.5.Regional Bifurcation
10.2.4.5.1.North America
10.2.4.5.1.1.Market Estimation, 2015 – 2022
10.2.4.5.1.2.Market Forecast, 2023 – 2031
10.2.4.5.2.Europe
10.2.4.5.2.1.Market Estimation, 2015 – 2022
10.2.4.5.2.2.Market Forecast, 2023 – 2031
10.2.4.5.3.Asia Pacific
10.2.4.5.3.1.Market Estimation, 2015 – 2022
10.2.4.5.3.2.Market Forecast, 2023 – 2031
10.2.4.5.4.Middle East and Africa
10.2.4.5.4.1.Market Estimation, 2015 – 2022
10.2.4.5.4.2.Market Forecast, 2023 – 2031
10.2.4.5.5.Latin America
10.2.4.5.5.1.Market Estimation, 2015 – 2022
10.2.4.5.5.2.Market Forecast, 2023 – 2031
10.3.Key Segment for Channeling Investments
10.3.1.By End-use
11.North America Blood Transfusion Diagnostics Market Analysis and Forecasts, 2023 – 2031
11.1.Overview
11.1.1.North America Blood Transfusion Diagnostics Market Revenue (US$ Mn)
11.2.North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
11.2.1.Reagents and Kits
11.2.2.Instruments
11.2.3.Others
11.3.North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
11.3.1.Blood Grouping
11.3.2.Disease Screening
11.3.2.1.Serological disease screening
11.3.2.2.Molecular disease screening
11.4.North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
11.4.1.Hospitals
11.4.2.Blood Banks
11.4.3.Diagnostic Laboratories
11.4.4.Others
11.5.North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1.U.S
11.5.1.1.U.S Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
11.5.1.1.1.Reagents and Kits
11.5.1.1.2.Instruments
11.5.1.1.3.Others
11.5.1.2.U.S Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.2.1.Blood Grouping
11.5.1.2.2.Disease Screening
11.5.1.2.2.1.Serological disease screening
11.5.1.2.2.2.Molecular disease screening
11.5.1.3.U.S Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
11.5.1.3.1.Hospitals
11.5.1.3.2.Blood Banks
11.5.1.3.3.Diagnostic Laboratories
11.5.1.3.4.Others
11.5.2.Canada
11.5.2.1.Canada Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
11.5.2.1.1.Reagents and Kits
11.5.2.1.2.Instruments
11.5.2.1.3.Others
11.5.2.2.Canada Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.2.1.Blood Grouping
11.5.2.2.2.Disease Screening
11.5.2.2.2.1.Serological disease screening
11.5.2.2.2.2.Molecular disease screening
11.5.2.3.Canada Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
11.5.2.3.1.Hospitals
11.5.2.3.2.Blood Banks
11.5.2.3.3.Diagnostic Laboratories
11.5.2.3.4.Others
11.5.3.Mexico
11.5.3.1.Mexico Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
11.5.3.1.1.Reagents and Kits
11.5.3.1.2.Instruments
11.5.3.1.3.Others
11.5.3.2.Mexico Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.2.1.Blood Grouping
11.5.3.2.2.Disease Screening
11.5.3.2.2.1.Serological disease screening
11.5.3.2.2.2.Molecular disease screening
11.5.3.3.Mexico Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
11.5.3.3.1.Hospitals
11.5.3.3.2.Blood Banks
11.5.3.3.3.Diagnostic Laboratories
11.5.3.3.4.Others
11.5.4.Rest of North America
11.5.4.1.Rest of North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
11.5.4.1.1.Reagents and Kits
11.5.4.1.2.Instruments
11.5.4.1.3.Others
11.5.4.2.Rest of North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
11.5.4.2.1.Blood Grouping
11.5.4.2.2.Disease Screening
11.5.4.2.2.1.Serological disease screening
11.5.4.2.2.2.Molecular disease screening
11.5.4.3.Rest of North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
11.5.4.3.1.Hospitals
11.5.4.3.2.Blood Banks
11.5.4.3.3.Diagnostic Laboratories
11.5.4.3.4.Others
11.6.Key Segment for Channeling Investments
11.6.1.By Country
11.6.2.By Product
11.6.3.By Application
11.6.4.By End-use
12.Europe Blood Transfusion Diagnostics Market Analysis and Forecasts, 2023 – 2031
12.1.Overview
12.1.1.Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn)
12.2.Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
12.2.1.Reagents and Kits
12.2.2.Instruments
12.2.3.Others
12.3.Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1.Blood Grouping
12.3.2.Disease Screening
12.3.2.1.Serological disease screening
12.3.2.2.Molecular disease screening
12.4.Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
12.4.1.Hospitals
12.4.2.Blood Banks
12.4.3.Diagnostic Laboratories
12.4.4.Others
12.5.Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1.France
12.5.1.1.France Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
12.5.1.1.1.Reagents and Kits
12.5.1.1.2.Instruments
12.5.1.1.3.Others
12.5.1.2.France Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.2.1.Blood Grouping
12.5.1.2.2.Disease Screening
12.5.1.2.2.1.Serological disease screening
12.5.1.2.2.2.Molecular disease screening
12.5.1.3.France Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
12.5.1.3.1.Hospitals
12.5.1.3.2.Blood Banks
12.5.1.3.3.Diagnostic Laboratories
12.5.1.3.4.Others
12.5.2.The UK
12.5.2.1.The UK Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
12.5.2.1.1.Reagents and Kits
12.5.2.1.2.Instruments
12.5.2.1.3.Others
12.5.2.2.The UK Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.2.1.Blood Grouping
12.5.2.2.2.Disease Screening
12.5.2.2.2.1.Serological disease screening
12.5.2.2.2.2.Molecular disease screening
12.5.2.3.The UK Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
12.5.2.3.1.Hospitals
12.5.2.3.2.Blood Banks
12.5.2.3.3.Diagnostic Laboratories
12.5.2.3.4.Others
12.5.3.Spain
12.5.3.1.Spain Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
12.5.3.1.1.Reagents and Kits
12.5.3.1.2.Instruments
12.5.3.1.3.Others
12.5.3.2.Spain Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.2.1.Blood Grouping
12.5.3.2.2.Disease Screening
12.5.3.2.2.1.Serological disease screening
12.5.3.2.2.2.Molecular disease screening
12.5.3.3.Spain Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
12.5.3.3.1.Hospitals
12.5.3.3.2.Blood Banks
12.5.3.3.3.Diagnostic Laboratories
12.5.3.3.4.Others
12.5.4.Germany
12.5.4.1.Germany Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
12.5.4.1.1.Reagents and Kits
12.5.4.1.2.Instruments
12.5.4.1.3.Others
12.5.4.2.Germany Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.2.1.Blood Grouping
12.5.4.2.2.Disease Screening
12.5.4.2.2.1.Serological disease screening
12.5.4.2.2.2.Molecular disease screening
12.5.4.3.Germany Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
12.5.4.3.1.Hospitals
12.5.4.3.2.Blood Banks
12.5.4.3.3.Diagnostic Laboratories
12.5.4.3.4.Others
12.5.5.Italy
12.5.5.1.Italy Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
12.5.5.1.1.Reagents and Kits
12.5.5.1.2.Instruments
12.5.5.1.3.Others
12.5.5.2.Italy Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.2.1.Blood Grouping
12.5.5.2.2.Disease Screening
12.5.5.2.2.1.Serological disease screening
12.5.5.2.2.2.Molecular disease screening
12.5.5.3.Italy Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
12.5.5.3.1.Hospitals
12.5.5.3.2.Blood Banks
12.5.5.3.3.Diagnostic Laboratories
12.5.5.3.4.Others
12.5.6.Nordic Countries
12.5.6.1.Nordic Countries Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
12.5.6.1.1.Reagents and Kits
12.5.6.1.2.Instruments
12.5.6.1.3.Others
12.5.6.2.Nordic Countries Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.6.2.1.Blood Grouping
12.5.6.2.2.Disease Screening
12.5.6.2.2.1.Serological disease screening
12.5.6.2.2.2.Molecular disease screening
12.5.6.3.Nordic Countries Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
12.5.6.3.1.Hospitals
12.5.6.3.2.Blood Banks
12.5.6.3.3.Diagnostic Laboratories
12.5.6.3.4.Others
12.5.6.4.Nordic Countries Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1.Denmark
12.5.6.4.2.Finland
12.5.6.4.3.Iceland
12.5.6.4.4.Sweden
12.5.6.4.5.Norway
12.5.7.Benelux Union
12.5.7.1.Benelux Union Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
12.5.7.1.1.Reagents and Kits
12.5.7.1.2.Instruments
12.5.7.1.3.Others
12.5.7.2.Benelux Union Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.2.1.Blood Grouping
12.5.7.2.2.Disease Screening
12.5.7.2.2.1.Serological disease screening
12.5.7.2.2.2.Molecular disease screening
12.5.7.3.Benelux Union Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
12.5.7.3.1.Hospitals
12.5.7.3.2.Blood Banks
12.5.7.3.3.Diagnostic Laboratories
12.5.7.3.4.Others
12.5.7.4.Benelux Union Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1.Belgium
12.5.7.4.2.The Netherlands
12.5.7.4.3.Luxembourg
12.5.8.Rest of Europe
12.5.8.1.Rest of Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
12.5.8.1.1.Reagents and Kits
12.5.8.1.2.Instruments
12.5.8.1.3.Others
12.5.8.2.Rest of Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.8.2.1.Blood Grouping
12.5.8.2.2.Disease Screening
12.5.8.2.2.1.Serological disease screening
12.5.8.2.2.2.Molecular disease screening
12.5.8.3.Rest of Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
12.5.8.3.1.Hospitals
12.5.8.3.2.Blood Banks
12.5.8.3.3.Diagnostic Laboratories
12.5.8.3.4.Others
12.6.Key Segment for Channeling Investments
12.6.1.By Country
12.6.2.By Product
12.6.3.By Application
12.6.4.By End-use
13.Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecasts, 2023 – 2031
13.1.Overview
13.1.1.Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn)
13.2.Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
13.2.1.Reagents and Kits
13.2.2.Instruments
13.2.3.Others
13.3.Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1.Blood Grouping
13.3.2.Disease Screening
13.3.2.1.Serological disease screening
13.3.2.2.Molecular disease screening
13.4.Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
13.4.1.Hospitals
13.4.2.Blood Banks
13.4.3.Diagnostic Laboratories
13.4.4.Others
13.5.Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1.China
13.5.1.1.China Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
13.5.1.1.1.Reagents and Kits
13.5.1.1.2.Instruments
13.5.1.1.3.Others
13.5.1.2.China Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.2.1.Blood Grouping
13.5.1.2.2.Disease Screening
13.5.1.2.2.1.Serological disease screening
13.5.1.2.2.2.Molecular disease screening
13.5.1.3.China Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
13.5.1.3.1.Hospitals
13.5.1.3.2.Blood Banks
13.5.1.3.3.Diagnostic Laboratories
13.5.1.3.4.Others
13.5.2.Japan
13.5.2.1.Japan Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
13.5.2.1.1.Reagents and Kits
13.5.2.1.2.Instruments
13.5.2.1.3.Others
13.5.2.2.Japan Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.2.1.Blood Grouping
13.5.2.2.2.Disease Screening
13.5.2.2.2.1.Serological disease screening
13.5.2.2.2.2.Molecular disease screening
13.5.2.3.Japan Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
13.5.2.3.1.Hospitals
13.5.2.3.2.Blood Banks
13.5.2.3.3.Diagnostic Laboratories
13.5.2.3.4.Others
13.5.3.India
13.5.3.1.India Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
13.5.3.1.1.Reagents and Kits
13.5.3.1.2.Instruments
13.5.3.1.3.Others
13.5.3.2.India Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.2.1.Blood Grouping
13.5.3.2.2.Disease Screening
13.5.3.2.2.1.Serological disease screening
13.5.3.2.2.2.Molecular disease screening
13.5.3.3.India Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
13.5.3.3.1.Hospitals
13.5.3.3.2.Blood Banks
13.5.3.3.3.Diagnostic Laboratories
13.5.3.3.4.Others
13.5.4.New Zealand
13.5.4.1.New Zealand Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
13.5.4.1.1.Reagents and Kits
13.5.4.1.2.Instruments
13.5.4.1.3.Others
13.5.4.2.New Zealand Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.4.2.1.Blood Grouping
13.5.4.2.2.Disease Screening
13.5.4.2.2.1.Serological disease screening
13.5.4.2.2.2.Molecular disease screening
13.5.4.3.New Zealand Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
13.5.4.3.1.Hospitals
13.5.4.3.2.Blood Banks
13.5.4.3.3.Diagnostic Laboratories
13.5.4.3.4.Others
13.5.5.Australia
13.5.5.1.Australia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
13.5.5.1.1.Reagents and Kits
13.5.5.1.2.Instruments
13.5.5.1.3.Others
13.5.5.2.Australia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.2.1.Blood Grouping
13.5.5.2.2.Disease Screening
13.5.5.2.2.1.Serological disease screening
13.5.5.2.2.2.Molecular disease screening
13.5.5.3.Australia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
13.5.5.3.1.Hospitals
13.5.5.3.2.Blood Banks
13.5.5.3.3.Diagnostic Laboratories
13.5.5.3.4.Others
13.5.6.South Korea
13.5.6.1.South Korea Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
13.5.6.1.1.Reagents and Kits
13.5.6.1.2.Instruments
13.5.6.1.3.Others
13.5.6.2.South Korea Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.2.1.Blood Grouping
13.5.6.2.2.Disease Screening
13.5.6.2.2.1.Serological disease screening
13.5.6.2.2.2.Molecular disease screening
13.5.6.3.South Korea Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
13.5.6.3.1.Hospitals
13.5.6.3.2.Blood Banks
13.5.6.3.3.Diagnostic Laboratories
13.5.6.3.4.Others
13.5.7.Southeast Asia
13.5.7.1.Southeast Asia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
13.5.7.1.1.Reagents and Kits
13.5.7.1.2.Instruments
13.5.7.1.3.Others
13.5.7.2.Southeast Asia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.2.1.Blood Grouping
13.5.7.2.2.Disease Screening
13.5.7.2.2.1.Serological disease screening
13.5.7.2.2.2.Molecular disease screening
13.5.7.3.Southeast Asia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
13.5.7.3.1.Hospitals
13.5.7.3.2.Blood Banks
13.5.7.3.3.Diagnostic Laboratories
13.5.7.3.4.Others
13.5.7.4.Southeast Asia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1.Indonesia
13.5.7.4.2.Thailand
13.5.7.4.3.Malaysia
13.5.7.4.4.Singapore
13.5.7.4.5.Rest of Southeast Asia
13.5.8.Rest of Asia Pacific
13.5.8.1.Rest of Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
13.5.8.1.1.Reagents and Kits
13.5.8.1.2.Instruments
13.5.8.1.3.Others
13.5.8.2.Rest of Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.8.2.1.Blood Grouping
13.5.8.2.2.Disease Screening
13.5.8.2.2.1.Serological disease screening
13.5.8.2.2.2.Molecular disease screening
13.5.8.3.Rest of Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
13.5.8.3.1.Hospitals
13.5.8.3.2.Blood Banks
13.5.8.3.3.Diagnostic Laboratories
13.5.8.3.4.Others
13.6.Key Segment for Channeling Investments
13.6.1.By Country
13.6.2.By Product
13.6.3.By Application
13.6.4.By End-use
14.Middle East and Africa Blood Transfusion Diagnostics Market Analysis and Forecasts, 2023 – 2031
14.1.Overview
14.1.1.Middle East and Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn)
14.2.Middle East and Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
14.2.1.Reagents and Kits
14.2.2.Instruments
14.2.3.Others
14.3.Middle East and Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1.Blood Grouping
14.3.2.Disease Screening
14.3.2.1.Serological disease screening
14.3.2.2.Molecular disease screening
14.4.Middle East and Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
14.4.1.Hospitals
14.4.2.Blood Banks
14.4.3.Diagnostic Laboratories
14.4.4.Others
14.5.Middle East and Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1.Saudi Arabia
14.5.1.1.Saudi Arabia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
14.5.1.1.1.Reagents and Kits
14.5.1.1.2.Instruments
14.5.1.1.3.Others
14.5.1.2.Saudi Arabia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.2.1.Blood Grouping
14.5.1.2.2.Disease Screening
14.5.1.2.2.1.Serological disease screening
14.5.1.2.2.2.Molecular disease screening
14.5.1.3.Saudi Arabia Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
14.5.1.3.1.Hospitals
14.5.1.3.2.Blood Banks
14.5.1.3.3.Diagnostic Laboratories
14.5.1.3.4.Others
14.5.2.UAE
14.5.2.1.UAE Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
14.5.2.1.1.Reagents and Kits
14.5.2.1.2.Instruments
14.5.2.1.3.Others
14.5.2.2.UAE Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.2.1.Blood Grouping
14.5.2.2.2.Disease Screening
14.5.2.2.2.1.Serological disease screening
14.5.2.2.2.2.Molecular disease screening
14.5.2.3.UAE Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
14.5.2.3.1.Hospitals
14.5.2.3.2.Blood Banks
14.5.2.3.3.Diagnostic Laboratories
14.5.2.3.4.Others
14.5.3.Egypt
14.5.3.1.Egypt Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
14.5.3.1.1.Reagents and Kits
14.5.3.1.2.Instruments
14.5.3.1.3.Others
14.5.3.2.Egypt Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.2.1.Blood Grouping
14.5.3.2.2.Disease Screening
14.5.3.2.2.1.Serological disease screening
14.5.3.2.2.2.Molecular disease screening
14.5.3.3.Egypt Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
14.5.3.3.1.Hospitals
14.5.3.3.2.Blood Banks
14.5.3.3.3.Diagnostic Laboratories
14.5.3.3.4.Others
14.5.4.Kuwait
14.5.4.1.Kuwait Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
14.5.4.1.1.Reagents and Kits
14.5.4.1.2.Instruments
14.5.4.1.3.Others
14.5.4.2.Kuwait Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.2.1.Blood Grouping
14.5.4.2.2.Disease Screening
14.5.4.2.2.1.Serological disease screening
14.5.4.2.2.2.Molecular disease screening
14.5.4.3.Kuwait Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
14.5.4.3.1.Hospitals
14.5.4.3.2.Blood Banks
14.5.4.3.3.Diagnostic Laboratories
14.5.4.3.4.Others
14.5.5.South Africa
14.5.5.1.South Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
14.5.5.1.1.Reagents and Kits
14.5.5.1.2.Instruments
14.5.5.1.3.Others
14.5.5.2.South Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.5.2.1.Blood Grouping
14.5.5.2.2.Disease Screening
14.5.5.2.2.1.Serological disease screening
14.5.5.2.2.2.Molecular disease screening
14.5.5.3.South Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
14.5.5.3.1.Hospitals
14.5.5.3.2.Blood Banks
14.5.5.3.3.Diagnostic Laboratories
14.5.5.3.4.Others
14.5.6.Rest of Middle East & Africa
14.5.6.1.Rest of Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
14.5.6.1.1.Reagents and Kits
14.5.6.1.2.Instruments
14.5.6.1.3.Others
14.5.6.2.Rest of Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.6.2.1.Blood Grouping
14.5.6.2.2.Disease Screening
14.5.6.2.2.1.Serological disease screening
14.5.6.2.2.2.Molecular disease screening
14.5.6.3.Rest of Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
14.5.6.3.1.Hospitals
14.5.6.3.2.Blood Banks
14.5.6.3.3.Diagnostic Laboratories
14.5.6.3.4.Others
14.6.Key Segment for Channeling Investments
14.6.1.By Country
14.6.2.By Product
14.6.3.By Application
14.6.4.By End-use
15.Latin America Blood Transfusion Diagnostics Market Analysis and Forecasts, 2023 – 2031
15.1.Overview
15.1.1.Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn)
15.2.Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
15.2.1.Reagents and Kits
15.2.2.Instruments
15.2.3.Others
15.3.Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
15.3.1.Blood Grouping
15.3.2.Disease Screening
15.3.2.1.Serological disease screening
15.3.2.2.Molecular disease screening
15.4.Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
15.4.1.Hospitals
15.4.2.Blood Banks
15.4.3.Diagnostic Laboratories
15.4.4.Others
15.5.Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1.Brazil
15.5.1.1.Brazil Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
15.5.1.1.1.Reagents and Kits
15.5.1.1.2.Instruments
15.5.1.1.3.Others
15.5.1.2.Brazil Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.2.1.Blood Grouping
15.5.1.2.2.Disease Screening
15.5.1.2.2.1.Serological disease screening
15.5.1.2.2.2.Molecular disease screening
15.5.1.3.Brazil Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
15.5.1.3.1.Hospitals
15.5.1.3.2.Blood Banks
15.5.1.3.3.Diagnostic Laboratories
15.5.1.3.4.Others
15.5.2.Argentina
15.5.2.1.Argentina Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
15.5.2.1.1.Reagents and Kits
15.5.2.1.2.Instruments
15.5.2.1.3.Others
15.5.2.2.Argentina Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.2.1.Blood Grouping
15.5.2.2.2.Disease Screening
15.5.2.2.2.1.Serological disease screening
15.5.2.2.2.2.Molecular disease screening
15.5.2.3.Argentina Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
15.5.2.3.1.Hospitals
15.5.2.3.2.Blood Banks
15.5.2.3.3.Diagnostic Laboratories
15.5.2.3.4.Others
15.5.3.Rest of Latin America
15.5.3.1.Rest of Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
15.5.3.1.1.Reagents and Kits
15.5.3.1.2.Instruments
15.5.3.1.3.Others
15.5.3.2.Rest of Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
15.5.3.2.1.Blood Grouping
15.5.3.2.2.Disease Screening
15.5.3.2.2.1.Serological disease screening
15.5.3.2.2.2.Molecular disease screening
15.5.3.3.Rest of Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Forecasts, By End-use
15.5.3.3.1.Hospitals
15.5.3.3.2.Blood Banks
15.5.3.3.3.Diagnostic Laboratories
15.5.3.3.4.Others
15.6.Key Segment for Channeling Investments
15.6.1.By Country
15.6.2.By Product
15.6.3.By Application
15.6.4.By End-use
16.Competitive Benchmarking
16.1.Market Share Analysis, 2022
16.2.Global Presence and Growth Strategies
16.2.1.Mergers and Acquisitions
16.2.2.Product Launches
16.2.3.Investments Trends
16.2.4.R&D Initiatives
17.Player Profiles
17.1.Abbott
17.1.1.Company Details
17.1.2.Company Overview
17.1.3.Product Offerings
17.1.4.Key Developments
17.1.5.Financial Analysis
17.1.6.SWOT Analysis
17.1.7.Business Strategies
17.2.Beckman Coulter, Inc.
17.2.1.Company Details
17.2.2.Company Overview
17.2.3.Product Offerings
17.2.4.Key Developments
17.2.5.Financial Analysis
17.2.6.SWOT Analysis
17.2.7.Business Strategies
17.3.BIOMERIEUX
17.3.1.Company Details
17.3.2.Company Overview
17.3.3.Product Offerings
17.3.4.Key Developments
17.3.5.Financial Analysis
17.3.6.SWOT Analysis
17.3.7.Business Strategies
17.4.Bio-Rad Laboratories, Inc.
17.4.1.Company Details
17.4.2.Company Overview
17.4.3.Product Offerings
17.4.4.Key Developments
17.4.5.Financial Analysis
17.4.6.SWOT Analysis
17.4.7.Business Strategies
17.5.F. Hoffmann-La Roche Ltd
17.5.1.Company Details
17.5.2.Company Overview
17.5.3.Product Offerings
17.5.4.Key Developments
17.5.5.Financial Analysis
17.5.6.SWOT Analysis
17.5.7.Business Strategies
17.6.Grifols, S.A.
17.6.1.Company Details
17.6.2.Company Overview
17.6.3.Product Offerings
17.6.4.Key Developments
17.6.5.Financial Analysis
17.6.6.SWOT Analysis
17.6.7.Business Strategies
17.7.MedGenome
17.7.1.Company Details
17.7.2.Company Overview
17.7.3.Product Offerings
17.7.4.Key Developments
17.7.5.Financial Analysis
17.7.6.SWOT Analysis
17.7.7.Business Strategies
17.8.Ortho Clinical Diagnostics
17.8.1.Company Details
17.8.2.Company Overview
17.8.3.Product Offerings
17.8.4.Key Developments
17.8.5.Financial Analysis
17.8.6.SWOT Analysis
17.8.7.Business Strategies
17.9.Quotient Suisse SA
17.9.1.Company Details
17.9.2.Company Overview
17.9.3.Product Offerings
17.9.4.Key Developments
17.9.5.Financial Analysis
17.9.6.SWOT Analysis
17.9.7.Business Strategies
17.10.Siemens Healthcare Private Limited
17.10.1.Company Details
17.10.2.Company Overview
17.10.3.Product Offerings
17.10.4.Key Developments
17.10.5.Financial Analysis
17.10.6.SWOT Analysis
17.10.7.Business Strategies
17.11.Other Market Participants
18.Key Findings

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

.

**Exclusive for Multi-User and Enterprise User.

Global Blood Transfusion Diagnostics Market Segmentation

By Product

 Reagents & kits
 Instruments
 Others

By Application

 Blood Grouping
 Disease Screening
 Serological disease screening
 Molecular disease screening

By End-use

 Hospitals
 Blood Banks
 Diagnostic Laboratories
 Others

By Region

 North America (U.S., Canada, Mexico, Rest of North America)
 Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
 Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
 Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
 Latin America (Brazil, Argentina, Rest of Latin America)

**Note: The report covers cross-segmentation analysis by region further into countries

.

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.

 

 

Procure Comprehensive Study of

Global Blood Transfusion Diagnostics Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top